Analysts Offer Predictions for CRSP Q1 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics in a research report issued to clients and investors on Tuesday, February 11th. Leerink Partnrs analyst M. Foroohar forecasts that the company will post earnings per share of […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics in a research report issued to clients and investors on Tuesday, February 11th. Leerink Partnrs analyst M. Foroohar forecasts that the company will post earnings per share of […]
